Japanese pharmaceutical firm Takeda has announced five new partnerships to its Global Corporate Social Respons...
Menarini Asia-Pacific has entered into a long-term exclusive licensing partnership with Japanese firm Astellas Pharma fo...
Japan-based pharmaceutical company Eisai has established a digital business company Theoria technologies Co. which will ...
Japanese firm Otsuka Pharmaceutical and US-based ShapeTX have announced a multi-target collaboration to develop intravit...
Onsite Coverage By Hithaishi Bhaskar The 23 rd edition of ISPE Singapore Affiliate's Conference and Exhibition 2023 was...
Guangzhou Gloria Biosciences (GloriaBio), a commercial stage biopharmaceutical company focusing on the discovery, develo...
Japan's RaQualia Pharma has announced that one of its sublicensees, United Italian Trading Corporation (UITC) has ...
Cipla South Africa, a 100% owned subsidiary of Indian pharmaceutical firm Cipla Limited, has signed a binding term sheet...
Japan-based Otsuka Pharmaceutical Co. and Canadian firm Mindset Pharma, Inc. have entered into a definitive arrangement ...
US-based Twist Bioscience Corporation has announced a drug discovery agreement with Japan headquartered O...
Can you provide an overview of TauRx Therapeutics? TauRx is dedicated to research in neurodegenerative diseases and is ...
Can you introduce the field of radiopharmaceuticals and the activities of Telix Pharma? Telix is an Australian-headquar...
Alzheimer's Disease (AD) is an escalating global health crisis. In 2020, the World Health Organisation (WHO) noted over ...
XtalPi Inc. (XtalPi), a leading technology platform company renowned for melding physics-based computation, artificial i...
Singapore-based biopharmaceutical company Specialised Therapeutics Asia (ST) will partner with Netherlands-based biotech...
US-based ImmunoGen, Inc., a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of c...
London-based Hikma Pharmaceuticals PLC has announced a new strategic partnership and exclusive licensing agreement...
Taiwan-based Formosa Pharmaceutical has entered into a licensing agreement with Eyenovia, whereby Eyenovia obtains exclu...
India-based Venus Remedies has launched its flagship R&D drug Elores in the $1.4 billion pharmaceutical market in Om...
The industry in Korea has seen its ‘growth potential’ increase by 7% in the 2023 CPHI Annual Survey. With th...
Japanese firm Astellas Pharma Inc. and US-based startup Poseida Therapeutics, Inc. have announced a strategic investment...
The Indian pharmaceutical industry has demonstrated impressive growth over the years, achieving a Compound Annual Growth...
Pharmanovia, a UK-based pharmaceutical company that commercialises novel medicines and revitalises, extends and expands ...
Israel-based biopharma firm MediWound has announced that its strategic partner, Kaken Pharmaceutical has launched NexoBr...
Taiwan's Lotus Pharmaceuticals and Ireland's Amarin Corporation have entered into a long-term exclusive partnership to d...
